Clinical Resources

Authored and endorsed clinical documents provide three main components vital to advancements in the heart rhythm field: analysis, discussion of current issues, and suggestions for clinical application. 

HRS Clinical Document Methodology

The HRS Clinical Document Development Methodology Manual and Policies transparently declares the standards by which the HRS develops clinical practice documents, which include clinical practice guidelines, expert consensus statements, scientific statements, clinical competency statements, task force policy statements, and proceedings statements.

2002 NASPE Position Statement: The Revised NASPE/BPEG Generic Code for Antibradycardia, Adaptive-Rate, and Multisite Pacing 

Device Therapy

February 2002—This Statement gives the revised NBG code, endorsed by the British Pacing and Electrophysiology Group (BPEG) and the North American Society of Pacing and Electrophysiology (NASPE, now known as Heart Rhythm Society) in 2001. This statement is more compatible with contemporary and emerging pacing technology with particular attention to the issue of multisite pacing.

This document was reaffirmed on February 7, 2018, and will be formally assessed by February 2023.

2011 HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

Allied Professional

August 2011—Genetic testing is increasingly important in determining potential cardiac conditions in patients and is used in clinical settings more than ever before. To ensure that physicians have up-to-date knowledge of the evolving role of genetic testing for sudden death predisposing, genetic heart diseases in cardiology, which can be lifesaving for some patients, the Heart Rhythm Society and the European Heart Rhythm Association have prepared HRS/EHRA Expert Consensus Statement on the State of Genetic Testing for the Channelopathies and Cardiomyopathies

This document was reaffirmed on April 11, 2018, and will be formally assessed by April 2023.

2011 Expert Consensus Statement on the Perioperative Management of Patients with Implantable Defibrillators, Pacemakers, and Arrhythmia Monitors

Device Therapy

July 2011—Developed as a joint project with the American Society of Anesthesiologists (ASA), and in collaboration with the American Heart Association (AHA) and the Society of Thoracic Surgeons (STS), a diverse panel of experts in pacemaker and defibrillator management focused on medical procedures that might interfere with cardiovascular implantable electronic devices (CIEDs) function.

2011 ACCF/AHA/HRS Focused Update on the Management of Patients with Atrial Fibrillation (Update on Dabigatran/2006 Guideline)

Atrial Arrhythmias

This document has been retired and replaced by "2014 AHA/ACC/HRS Guideline for the Management of Patients with Atrial Fibrillation."

February 14, 2011—This guideline update states that dabigatran, a new antithrombotic agent that was recently approved by the U.S. Food and Drug Administration, is an alternative to warfarin to help prevent dangerous blood clots in patients with atrial fibrillation. The update is a joint publication of the American College of Cardiology Foundation (ACCF), the American Heart Association (AHA), and the Heart Rhythm Society (HRS). 

2010 SCAI/ACCF/HRS/ESC/SOLACI/APSIC Statement on the Use of Live Case Demonstrations at Cardiology Meetings: Assessments of the Past and Standards for the Future

Training

September 21, 2010 – This statement is the result of a collaborative effort with interventional cardiologists and electrophysiology members from the Heart Rhythm Society (HRS). The document outlines and recommends standards for medical practitioners to use when performing and broadcasting live cardiovascular case demonstrations at medical meetings.

2010 A Heart Rhythm Society Electrophysiology Workforce Study: Current Survey Analysis of Physician Workforce Trends

Clinical Ep

August 31, 2010 — A new study on overall workforce trends in the field of cardiac electrophysiology (EP) reveals an increasing demand for EP professionals resulting from shifting demographic trends, evolving health reform policies, and improved procedural outcomes. The study, commissioned in 2009 by the Heart Rhythm Society, provides data from nearly 700 respondents, including EPs, allied professionals, and basic scientists currently working within the field of cardiac electrophysiology. It found substantial growth in the overall volume and complexity of cardiac procedures performed in the past decade.

2010 HRS Expert Consensus Statement on the Management of Cardiovascular Implantable Electronic Devices (CIEDs) in Patients Nearing End of Life or Requesting Withdrawal of Therapy

Ventricular Arrhythmias

May 17, 2010—This document was developed in collaboration with and endorsed by the American College of Cardiology (ACC), the American Geriatrics Society (AGS), the American Academy of Hospice and Palliative Medicine (AAHPM), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), and the Hospice and Palliative Nurses Association (HPNA). It focuses on patients nearing the end of life and addresses patients who have made a decision for CIED deactivation at other times, as well as the rights and responsibilities of clinicians (and others, such as industry-employed allied professionals) who may not wish to perform deactivation.

This document was reaffirmed on March 7, 2018, and will be formally assessed by March 2023.